[1] 中国老年学学会骨质疏松委员会骨质疏松诊断标准学科组. 中国人原发性骨质疏松症诊断标准(试行) [J]. 中国骨质疏松杂志 1999.doi:10.3969/j.issn.1006-7108.1999.01.001 [2] 胡朝晖. 国产阿仑磷酸钠防治绝经后骨质疏松症 [J]. 浙江临床医学 2004.doi:10.3969/j.issn.1008-7664.2004.03.049 [3] 肖建德, 阎德文, 吴清平, 李卓成, 吴建龙, 孙月玲. 阿仑膦酸钠治疗绝经后骨质疏松症的临床观察 [J]. 中国骨质疏松杂志 2000.doi:10.3969/j.issn.1006-7108.2000.02.011 [4] 乐杰. 妇产科学 [M]. 北京:人民出版社 2001. [5] 徐顺民, 余京梅. 绝经后骨质疏松症的药物治疗进展 [J]. 国外医学(老年医学分册) 1999, 20(02). [6] 姚吉龙. 双膦酸盐抑制骨吸收机制及其防治骨质疏松症的研究进展 [J]. 1998. [7] Ernandez CJ, Beaupre GS, Marcua R. Aoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment [J]. Bone 2001, 28(03). [8] Braga de-Castro-Machado-A, Hannon R, Eastell R. Monitoring alendronate therapy for osteoporosis. [J]. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 1999, 4(4). [9] Arm C, George W, Andrew W. Meta Analysis of Alendronate for the Treatment of Postmenopausal Women [J]. Endocrin Revieus 2002, 23(04). |